MED-Cli: Prospective Observational Study to Characterize Patients Treated at Internal Medicine Clinics

Sponsor
IRCCS San Raffaele (Other)
Overall Status
Recruiting
CT.gov ID
NCT05780099
Collaborator
(none)
50,000
2
122.6
25000
204

Study Details

Study Description

Brief Summary

Patients referred to internal medicine wards are becoming increasingly complex and fragile. Despite deep knowledge of their specific disorders, steps are required to improve overall management of their acute and chronic conditions. The main objective of the study is to identify demographic, clinical, laboratory and radiological markers of disease severity and activity in patients with diseases treated at general medicine wards (respiratory disease, immune-mediated disease, sepsis, metabolic disease, rare disease, frailty, pregnancy pathology) in order to improve their diagnosis, monitoring and treatment processes.

Study Design

Study Type:
Observational
Anticipated Enrollment :
50000 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Prospective Observational Study to Characterize Patients Treated at Internal Medicine Clinics
Actual Study Start Date :
Jun 24, 2022
Anticipated Primary Completion Date :
Sep 10, 2031
Anticipated Study Completion Date :
Sep 10, 2032

Arms and Interventions

Arm Intervention/Treatment
Cases

patients treated at internal medicine wards

Other: Inpatient or Outpatient visit
Patients will be seen and treated at the clinics like in the usual care

Outcome Measures

Primary Outcome Measures

  1. Number of participants with severe disease [The following variables will be collected during patient enrollment]

    Identify demographic, clinical, laboratory and radiological markers of disease severity and activity

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Receving treatment at internal medicine departments (inpatient, outopatient, day hospital) of San Raffaele Hospital

  • at least one suspected or confirmed diagnosis among:

  1. immune mediated disorder

  2. respiratory disorder

  3. metabolic disorder

  4. sepsis

  5. rare disorder (according to Italian Ministry of Health list)

  6. pregnancy-related disorder

  7. frailty defined as: either ≥2 CIRS (Cumulative Illness Rating Scale) Severity Index 10 or ≤70% Karnofsky scale

Exclusion Criteria:
  • refusal to participate

  • enrolment in other intervantional study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ospedale San Raffaele Milan Italy
2 San Raffaele Hospital Milan Italy

Sponsors and Collaborators

  • IRCCS San Raffaele

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Rovere Querini Patrizia, Director, IRCCS San Raffaele
ClinicalTrials.gov Identifier:
NCT05780099
Other Study ID Numbers:
  • MED-Cli
First Posted:
Mar 22, 2023
Last Update Posted:
Mar 28, 2023
Last Verified:
Mar 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 28, 2023